Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in chronic kidney disease.
The normal intestinal microbiota plays a major role in the maintenance of health and disease prevention. In fact, the alteration of the intestinal microbiota has been shown to contribute to the pathogenesis of several pathological conditions, including obesity and insulin resistance, among others. Recent studies have revealed profound alterations of the gut microbial flora in patients and animals with chronic kidney disease (CKD). Alterations in the composition of the microbiome in CKD may contribute to the systemic inflammation and accumulation of gut-derived uremic toxins, which play a central role in the pathogenesis of accelerated cardiovascular disease and numerous other CKD-associated complications. This review is intended to provide a concise description of the potential role of the CKD-associated changes in the gut microbiome and its potential role the pathogenesis of inflammation and uremic toxicity. In addition, the potential efficacy of pre- and pro-biotics in the restoration of the microbiome is briefly described.
Medical Sciences Graduate Program, Federal University Fluminense (UFF), Niterói-RJ, Brazil.
Denise
D
Mafra
Julie C
JC
Lobo
Amanda F
AF
Barros
Laetitia
L
Koppe
Nosratola D
ND
Vaziri
Denis
D
Fouque
D000818:Animals; D050260:Carbohydrate Metabolism; D002318:Cardiovascular Diseases / Q000209:etiology*; D005223:Fats / Q000378:metabolism; D005260:Female; D006801:Humans; D007249:Inflammation / Q000209:etiology*; D007413:Intestinal Mucosa / Q000378:metabolism; D007422:Intestines / Q000382:microbiology*; D008070:Lipopolysaccharides / Q000378:metabolism; D008297:Male; D064307:Microbiota; D056692:Prebiotics; D011247:Pregnancy; D019936:Probiotics; D011506:Proteins / Q000378:metabolism; D051436:Renal Insufficiency, Chronic / Q000150:complications* / Q000378:metabolism / Q000382:microbiology*
D005223:Fats; D008070:Lipopolysaccharides; D056692:Prebiotics; D011506:Proteins